安进(AMGN.US)涨6% 三季度销售额超预期并上调全年业绩指引

Core Insights - Amgen (AMGN.US) shares rose by 6% to $314.58 following strong Q3 earnings results [1] - The company's Q3 sales increased by 12% year-over-year to $9.56 billion, surpassing analyst expectations of $8.97 billion [1] - Adjusted earnings per share (EPS) were reported at $5.64, exceeding the forecast of $5.01 [1] - Amgen raised its full-year guidance, projecting sales between $35.8 billion and $36.6 billion, and EPS between $20.6 and $21.4 [1]